(338) Nuclear Factor Kappa Beta Subunit 2 Genotype and Pain in Postmenopausal Women with Early-Stage Breast Cancer Prior Treatment

M. Wagner; Y. Zhu; C. Bender; Y. Conley

doi:10.1016/j.jpain.2019.02.034

(338) Nuclear Factor Kappa Beta Subunit 2 Genotype and Pain in Postmenopausal Women with Early-Stage Breast Cancer Prior Treatment

Journal of Pain ◽

10.1016/j.jpain.2019.02.034 ◽

2019 ◽

Vol 20 (4) ◽

pp. S59

Author(s):

M. Wagner ◽

Y. Zhu ◽

C. Bender ◽

Y. Conley

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Early Stage ◽

Prior Treatment ◽

Beta Subunit ◽

Early Stage Breast Cancer ◽

Nuclear Factor ◽

Nuclear Factor Kappa ◽

Nuclear Factor Kappa Beta

Download Full-text

Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole

The Journal of Clinical Pharmacology ◽

10.1177/0091270011424153 ◽

2012 ◽

Vol 52 (12) ◽

pp. 1852-1860 ◽

Cited By ~ 20

Author(s):

Lauren Nicole Bell ◽

Anne Thi Phuong Nguyen ◽

Lang Li ◽

Zeruesenay Desta ◽

N. Lynn Henry ◽

...

Keyword(s):

Breast Cancer ◽

Lipid Profile ◽

Postmenopausal Women ◽

Early Stage ◽

Early Stage Breast Cancer

Download Full-text

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2004.01.008 ◽

2004 ◽

Vol 30 (3) ◽

pp. 303-307

Author(s):

Hetty Carraway ◽

Antonio C. Wolff

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Early Stage ◽

Early Stage Breast Cancer

Download Full-text

Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05715-1 ◽

2020 ◽

Vol 182 (2) ◽

pp. 259-266

Author(s):

Daniel Reinhorn ◽

Rinat Yerushalmi ◽

Assaf Moore ◽

Alexandra Desnoyers ◽

Ramy R. Saleh ◽

...

Keyword(s):

Breast Cancer ◽

Adverse Events ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Early Stage ◽

Adjuvant Endocrine Therapy ◽

Early Stage Breast Cancer

Download Full-text

Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK

Annals of Oncology ◽

10.1093/annonc/mdp560 ◽

2010 ◽

Vol 21 (7) ◽

pp. 1529-1536 ◽

Cited By ~ 13

Author(s):

J.F.S. Logman ◽

B.M.S. Heeg ◽

M.F. Botteman ◽

S. Kaura ◽

B.A. van Hout

Keyword(s):

Breast Cancer ◽

Economic Evaluation ◽

Zoledronic Acid ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Early Stage ◽

Osteoporotic Fractures ◽

Early Stage Breast Cancer ◽

The Uk

Download Full-text

Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women

Recent Advances in Medicinal Chemistry ◽

10.1016/b978-0-12-803961-8.50004-x ◽

2014 ◽

pp. 99-130

Author(s):

Mariantonietta Colozza ◽

Elisa Minenza ◽

Martina Nunzi ◽

Silvia Sabatini ◽

Phuong Dinh ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Endocrine Treatment

Download Full-text

Abstract P2-12-01: Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer

10.1158/0008-5472.sabcs12-p2-12-01 ◽

2012 ◽

Author(s):

KD Crew ◽

Makarem D Chehayeb ◽

D Awad ◽

K Kalinsky ◽

M Maurer ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Prospective Evaluation ◽

Joint Symptoms

Download Full-text

Abstract OT1-1-01: LORELEI: A Phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early stage breast cancer

10.1158/1538-7445.sabcs14-ot1-1-01 ◽

2015 ◽

Author(s):

Cristina Saura ◽

Evandro de Azambuja ◽

Peter Dubsky ◽

Mafalda Oliveira ◽

Kamal S Saini ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Early Stage ◽

Blind Study ◽

Early Stage Breast Cancer ◽

Double Blind Study ◽

Double Blind ◽

Er Positive

Download Full-text

Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30334-1 ◽

2019 ◽

Vol 20 (9) ◽

pp. 1226-1238 ◽

Cited By ~ 20

Author(s):

Cristina Saura ◽

Dominik Hlauschek ◽

Mafalda Oliveira ◽

Dimitrios Zardavas ◽

Anita Jallitsch-Halper ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Oestrogen Receptor ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial

Download Full-text

Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole

The Breast ◽

10.1016/j.breast.2008.05.008 ◽

2008 ◽

Vol 17 (6) ◽

pp. 631-636 ◽

Cited By ~ 11

Author(s):

Mario Valenzano Menada ◽

Sergio Costantini ◽

Melita Moioli ◽

Stefano Bogliolo ◽

Andrea Papadia ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Early Stage ◽

Endometrial Thickness ◽

Early Stage Breast Cancer ◽

Tamoxifen Treatment ◽

Adjuvant Tamoxifen ◽

Hormone Receptor Positive

Download Full-text

Adjuvant Aromatase Inhibitors Following Tamoxifen for Early-Stage Breast Cancer in Postmenopausal Women: What Do We Really Know?

Clinical Breast Cancer ◽

10.3816/cbc.2004.s.010 ◽

2004 ◽

Vol 5 ◽

pp. S18-S23 ◽

Cited By ~ 2

Author(s):

Cathie T. Chung ◽

Robert W. Carlson

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Early Stage ◽

Early Stage Breast Cancer

Download Full-text